Results 261 to 270 of about 155,094 (383)
GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu +11 more
wiley +1 more source
The cross-talk and interplay between ferroptosis and cuproptosis in tumor and therapeutics. [PDF]
Zhou X, Peng S.
europepmc +1 more source
A multifunctional nano immunostimulant is first proposed for efficient tumor immunotherapy. The ER targeted ability, superior ROS production, efficient GSH consumption, coupled with the HIF suppression, jointly arouses ICD/ferroptosis pathways to realize efficient tumor immunotherapy.
Guanhong Guo +14 more
wiley +1 more source
Ferroptosis: a new dawn in the treatment of acute lymphoblastic leukemia. [PDF]
Han J, Yang Y, Wei Y, Jin J, Feng W.
europepmc +1 more source
Telomerase reverse transcriptase (TERT) mRNA induces DNA self‐assembly in cancer cells, boosting the nanoplatform's magnetothermal properties. This magnetothermia then activates the Hsp70 promoter, initiating siRNA synthesis to silence the TERT gene, enhancing cancer treatment.
Liang Zhang +9 more
wiley +1 more source
Research progress of ferroptosis in cervical cancer treatment. [PDF]
Wang F, Wang L, Bai Y.
europepmc +1 more source
This study develops an iridium‐based nanozyme (IIN@M) with superior enzyme‐like activity and photothermal performance. It disrupts intracellular redox balance by generating reactive oxygen species and depleting glutathione, which synergistically induces ferroptosis, pyroptosis, and immunogenic cell death.
Lijun Ding +7 more
wiley +1 more source
Research Progress in Ferroptosis for Digestive Carcinoma [PDF]
Xiang‐Yan Liu
openalex +1 more source

